1.Ota T, Suzuki Y, Nishikawa T, et al.: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004, 36:40-45.
2.陳桂秋: 人類基因ROGDI 蛋白質多株抗體製備及初步特性分析. 國立中山大學生物科學研究所碩士論文. 2006.3.莊子慧: 人類 ROGDI 蛋白之功能性分析. 國立中山大學生物科學研究所碩士論文. 2007.4.劉仁超: 一個調控大鼠肝星狀細胞增生、移動與活化的新基因 Rogdi 國立中山大學生物科學研究所碩士論文. 2009.5.Norbury C, Nurse P: Animal cell cycles and their control. Annu Rev Biochem. 1992, 61:441-470.
6.Pardee AB, Dubrow R, Hamlin JL, Kletzien RF: Animal cell cycle. Annu Rev Biochem. 1978, 47:715-750.
7.Baserga R: Growth in size and cell DNA replication. Exp Cell Res. 1984, 151:1-5.
8.Baserga R: Biochemical events in the cell cycle. Natl Cancer Inst Monogr. 1969, 30:1-14.
9.Hanna DE, Rethinaswamy A, Glover CV: Casein kinase II is required for cell cycle progression during G1 and G2/M in Saccharomyces cerevisiae. J Biol Chem. 1995, 270:25905-25914.
10.Paulovich AG, Toczyski DP, Hartwell LH: When checkpoints fail. Cell. 1997, 88:315-321.
11.Resnitzky D, Hengst L, Reed SI: Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell Biol. 1995, 15:4347-4352.
12.Gu Y, Turck CW, Morgan DO: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature. 1993, 366:707-710.
13.Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993, 75:805-816.
14.Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 1992, 71:505-514.
15.Firpo EJ, Koff A, Solomon MJ, Roberts JM: Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol. 1994, 14:4889-4901.
16.Polyak K, Kato JY, Solomon MJ, et al.: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 1994, 8:9-22.
17.Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 1994, 78:67-74.
18.Matsuoka S, Edwards MC, Bai C, et al.: p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995, 9:650-662.
19.Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.
20.Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G: Cyclin A is required at two points in the human cell cycle. EMBO J. 1992, 11:961-971.
21.Preisig PA, Franch HA: Renal epithelial cell hyperplasia and hypertrophy. Semin Nephrol. 1995, 15:327-340.
22.Ohi R, Gould KL: Regulating the onset of mitosis. Curr Opin Cell Biol. 1999, 11:267-273.
23.Yang J, Kornbluth S: All aboard the cyclin train: subcellular trafficking of cyclins and their CDK partners. Trends Cell Biol. 1999, 9:207-210.
24.Rosenblatt J, Gu Y, Morgan DO: Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Natl Acad Sci U S A. 1992, 89:2824-2828.
25.Furuno N, den Elzen N, Pines J: Human cyclin A is required for mitosis until mid prophase. J Cell Biol. 1999, 147:295-306.
26.den Elzen N, Pines J: Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J Cell Biol. 2001, 153:121-136.
27.Geley S, Kramer E, Gieffers C, et al.: Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol. 2001, 153:137-148.
28.Girard F, Strausfeld U, Fernandez A, Lamb NJ: Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 1991, 67:1169-1179.
29.Saha P, Chen J, Thome KC, et al.: Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase. Mol Cell Biol. 1998, 18:2758-2767.
30.Petersen BO, Lukas J, Sorensen CS, Bartek J, Helin K: Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J. 1999, 18:396-410.
31.Coverley D, Laman H, Laskey RA: Distinct roles for cyclins E and A during DNA replication complex assembly and activation. Nat Cell Biol. 2002, 4:523-528.
32.Jeffrey PD, Russo AA, Polyak K, et al.: Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 1995, 376:313-320.
33.Selvakumaran M, Lin HK, Miyashita T, et al.: Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene. 1994, 9:1791-1798.
34.Wang XW, Vermeulen W, Coursen JD, et al.: The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev. 1996, 10:1219-1232.
35.Lundberg AS, Weinberg RA: Control of the cell cycle and apoptosis. Eur J Cancer. 1999, 35:1886-1894.
36.Whitfield ML, Sherlock G, Saldanha AJ, et al.: Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell. 2002, 13:1977-2000.
37.Stuurman N, Heins S, Aebi U: Nuclear lamins: their structure, assembly, and interactions. J Struct Biol. 1998, 122:42-66.
38.Herrmann H, Foisner R: Intermediate filaments: novel assembly models and exciting new functions for nuclear lamins. Cell Mol Life Sci. 2003, 60:1607-1612.
39.Broers JL, Machiels BM, van Eys GJ, et al.: Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. J Cell Sci. 1999, 112 ( Pt 20):3463-3475.
40.Moir RD, Yoon M, Khuon S, Goldman RD: Nuclear lamins A and B1: different pathways of assembly during nuclear envelope formation in living cells. J Cell Biol. 2000, 151:1155-1168.
41.Vesely J, Havlicek L, Strnad M, et al.: Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem. 1994, 224:771-786.
42.Bartek J, Lukas J: Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 2001, 490:117-122.
43.Saunders EL, Meredith MJ, Eisert DR, Freeman ML: Depletion of glutathione after gamma irradiation modifies survival. Radiat Res. 1991, 125:267-276.
44.Lamond AI, Carmo-Fonseca M: The coiled body. Trends Cell Biol. 1993, 3:198-204.
45.Ascoli CA, Maul GG: Identification of a novel nuclear domain. J Cell Biol. 1991, 112:785-795.
46.Brasch K, Ochs RL: Nuclear bodies (NBs): a newly "rediscovered" organelle. Exp Cell Res. 1992, 202:211-223.
47.Hozak P, Jackson DA, Cook PR: Replication factories and nuclear bodies: the ultrastructural characterization of replication sites during the cell cycle. J Cell Sci. 1994, 107 ( Pt 8):2191-2202.
48.Chamovitz DA, Wei N, Osterlund MT, et al.: The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch. Cell. 1996, 86:115-121.
49.Kato JY, Yoneda-Kato N: Mammalian COP9 signalosome. Genes Cells. 2009, 14:1209-1225.
50.von Arnim AG, Deng XW: Light inactivation of Arabidopsis photomorphogenic repressor COP1 involves a cell-specific regulation of its nucleocytoplasmic partitioning. Cell. 1994, 79:1035-1045.
51.Tomoda K, Kubota Y, Kato J: Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature. 1999, 398:160-165.
52.Oh W, Yang MR, Lee EW, et al.: Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. J Biol Chem. 2006, 281:30166-30174.
53.Huang J, Yuan H, Lu C, et al.: Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex. J Mol Biol. 2007, 371:514-527.
54.Oh W, Lee EW, Sung YH, et al.: Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem. 2006, 281:17457-17465.
55.Porter LA, Dellinger RW, Tynan JA, et al.: Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. J Cell Biol. 2002, 157:357-366.
56.van den Heuvel S, Harlow E: Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 1993, 262:2050-2054.
57.Resnitzky D, Reed SI: Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol. 1995, 15:3463-3469.
58.Sionov RV, Haupt Y: The cellular response to p53: the decision between life and death. Oncogene. 1999, 18:6145-6157.